| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Cytogenetics, Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany
Alterations of the distal portion of the short arm of chromosome 1 (1p) are among the earliest abnormalities of human colorectal tumors. Loss of heterozygosity analysis has previously revealed a smallest region of overlapping deletion (SRO) B, at 1p35-36.1, deleted in 48% of sporadic tumors. From this region we have now cloned a gene encoding a protein of 330 amino acids that is 78% identical with the Rattus norvegicus aflatoxin B1 aldehyde reductase (Afar) and, therefore, likely represents its human homologue. In rat liver, Afar is strongly inducible by the antioxidants ethoxyquin and butylated hydroxyanisole, which protect the rat against aflatoxin B1-induced liver tumorigenesis by detoxifying its genotoxic and cytotoxic dialdehyde. Human AFAR is expressed in a broad range of tissues and, therefore, is likely involved in endogenous detoxication pathways. Impaired detoxication of genotoxic aldehydes and ketones, which are involved in tumorigenesis of the colon and breast, may be a crucial factor both for tumor initiation and progression. We here provide a detailed contig of 1.52 Mbp/2.7 cM encompassing part of SRO B, including known genes and previously unmapped expressed sequence tags. PLA2G2A (secretory type II phospholipase A2), described previously as a candidate, is localized outside SRO B.
1 Supported by the Dr. Mildred Scheel Stiftung, the Cooperation Program in Cancer Research of the Deutsches Krebsforschungszentrum (DKFZ) and Israeli's Ministry of Science (MOS), and the Heidelberg-Mannheim Comprehensive Tumor Center.
2 To whom requests for reprints should be addressed, at Division of Cytogenetics-H0400, Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany. Phone: 49-6221-423220; Fax: 49-6221-423277; E-mail: m.schwab@dkfz-heidelberg.de.
Received 8/20/98. Accepted 10/ 1/98.
This article has been cited by other articles:
![]() |
E. M. Ellis, C. M. Slattery, and J. D. Hayes Characterization of the rat aflatoxin B1 aldehyde reductase gene, AKR7A1. Structure and chromosomal localization of AKR7A1 as well as identification of antioxidant response elements in the gene promoter Carcinogenesis, April 1, 2003; 24(4): 727 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Diep, L. Thorstensen, G. I. Meling, E. Skovlund, T. O. Rognum, and R. A. Lothe Genetic Tumor Markers With Prognostic Impact in Dukes' Stages B and C Colorectal Cancer Patients J. Clin. Oncol., March 1, 2003; 21(5): 820 - 829. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kozma, E. Brown, E. M. Ellis, and A. J. Lapthorn The Crystal Structure of Rat Liver AKR7A1. A DIMERIC MEMBER OF THE ALDO-KETO REDUCTASE SUPERFAMILY J. Biol. Chem., May 3, 2002; 277(18): 16285 - 16293. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. P. Kelly, E. M. Ellis, M. M. Manson, S. A. Chanas, G. J. Moffat, R. McLeod, D. J. Judah, G. E. Neal, and J. D. Hayes Chemoprevention of Aflatoxin B1 Hepatocarcinogenesis by Coumarin, a Natural Benzopyrone That Is a Potent Inducer of Aflatoxin B1-Aldehyde Reductase, the Glutathione S-Transferase A5 and P1 Subunits, and NAD(P)H:Quinone Oxidoreductase in Rat Liver Cancer Res., February 1, 2000; 60(4): 957 - 969. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |